In the aftermath of RFK Jr's appointment as the extremely influential secretary of Health and Human Services, a position which determines the fate of trillions in government spending, pharma stocks - especially those with a vaccine bent - have gotten crushed.
But the plunge in pharma shareholder value is just the first casualty of RFK Jr's arrival.
